期刊文献+

P53抑制剂诱导大鼠骨髓间充质干细胞向心肌样细胞分化的实验研究 被引量:3

Experimental study of differentiating bone marrow mesenchymal stem cells into cardiomyocyte-like cells by P53 inhibitor
原文传递
导出
摘要 目的研究P53特异性抑制剂对骨髓间充质干细胞向心肌样细胞分化的影响。方法分离SD大鼠骨髓间充质干细胞,取第4代骨髓间充质干细胞分为对照组(CON)和P53特异性抑制剂(PFT-α)组。观察骨髓间充质干细胞诱导前后细胞形态变化,流式细胞仪鉴定骨髓间充质干细胞表面抗原及诱导后心肌样细胞分化率,免疫荧光法检测诱导后cTnI、CX-43表达,Western Blot法测定诱导后cTnI、P53、P21蛋白表达情况。结果原代培养的骨髓间充质干细胞2周形成集落,传代诱导后细胞体积变大,呈长梭形,排列趋一致。流式细胞仪测定骨髓间充质干细胞表面抗原CD44阳性表达率为(89.98±1.29)%,CD45阳性表达率为(2.14±0.22)%。心肌样细胞鉴定结果显示:诱导后1周,空白对照组未见cTnI和CX-43免疫荧光表达,PFT-α组少量表达cTnI和CX-43;诱导后4周时,可见空白对照组少量表达cTnI和CX-43,PFT-α组强表达cTnI和CX-43。WesternBlot检测诱导1周时PFT-α组cTnI表达与对照组比较,有统计学差异(P<0.01)。诱导后4周,PFT-α组cTnI表达与对照组比较,有统计学差异(P<0.01)。两组cTnI表达量4周与1周比较有统计学差异(P<0.05)。诱导1周时,PFT-α组几乎不表达P53蛋白,PFT-α组与对照组比较有统计学差异(P<0.05)。诱导4周时,PFT-α组与对照组比较有统计学差异(P<0.05)。PFT-α组诱导4周时P53、P21表达量与1周时比较均有统计学差异(P<0.05)。心肌细胞分化率结果显示,诱导4周时,PFT-α组与空白对照组比较有统计学差异(P<0.01)。结论通过P53特异性抑制剂PFT-α阻断P53-P21蛋白通路,能诱导骨髓间充质干细胞向心肌样细胞分化。 Objective Recently p53 is shown to play an important role in the proliferation and differentiation of bone marrow mesenchymal stem cells(BMMSCs).Methods BMMSCs were isolated from bone marrow of SD rats by density gradient centrifugation.The fourth passage cells were divided into two groups:control group and PFT-α group.The purified BMMSCs were identified by surface antigens and the differentiation rate of BMMSCs was examined by flow cytometry analysis.The expressions of cTnI and CX-43 in BMMSCs after inductions were detected by immunofluorescence microcscopy and those of cTnI,p53 and p21 were detected by Western blot Assay.Results BMSCs of primary culture form colonies at 2 w,passaged cells became larger,elongated spindle,arranged the same trend.At 4 w after induction,BMMSCs represented as closely packed elongated cells with uniform morphology.The results of flow cytometry showed CD44 expression of BMSCs was(89.98±1.29)%,CD45 positive expression rate was(2.14±0.22)%.Immunofluorescence staining showed that at 1 w after induction,no expression of cTnI and CX-43 was observed in CON group,but a little expression of cTnI and CX-43 were observed in the PFT-α group.4 w after induction,CON group only had little expression of cTnI and CX-43,while the PFT-α group demonstrated strong expression of cTnI and CX-43.Western blotting analysis showed that at 1 w after induction,cTnI expression in the PFT-α group,but no cTnI expression was observed in CON group.At 4 w,only a little expression of cTnI was observed in CON group,but in the PFT-α group cTnI expression were significantly increased and much higher than CON group.cTnI expression in every group at 4 w was higher than that of at 1 w.Western blotting analysis showed that at 1 w the expression of p53 and p21 in CON group were stronger compare to PFT-α group(P<0.05),but no expression was observed in PFT-α group.At 4 w,the expression of p53 and p21 in CON group were still strong(P<0.05).The expression of p53 and p21 in PFT-α group and CON group at 4 w were much higher than that of at 1 w(P<0.05).Flow cytometry determined the differentiation rate of cardiomyocyte-like cells and the results showed that differentiation rate of PFT-α group was significant higher than CON group(P<0.01).Conclusions These data open up new possibility of modulating p53-p21 pathway for directed differentiation of BMMSCs into cardiomyocytes,which will be valuable for cardiovascular regenerative medicine.
出处 《中华临床医师杂志(电子版)》 CAS 2011年第10期2878-2885,共8页 Chinese Journal of Clinicians(Electronic Edition)
关键词 间充质干细胞 心肌 肿瘤抑制蛋白质P53 癌基因蛋白质P21(ras) Mesenchymal stem cells Myocardium Tumor suppressor protein p53 Oncogene protein p21(ras)
  • 相关文献

参考文献22

  • 1丁刚,丁晓玲,刘怡.骨髓间充质干细胞在临床医学中的应用[J].中华临床医师杂志(电子版),2008,2(10):60-64. 被引量:6
  • 2王建安,谢小洁,何红,孙勇,蒋峻,骆荣华,樊友启,董樑.骨髓间质干细胞移植治疗原发性扩张型心肌病的疗效与安全性[J].中华心血管病杂志,2006,34(2):107-110. 被引量:44
  • 3Dalziel SR,Parag V,Rodgers A,et al.Cardiovascular risk factors at age30following pre-term birth. International Journal of Epidemiology . 2007
  • 4Cao F,Sun DD,Li CX,et al.Long-term myocardial functional improvement after autologous bone marrow mononuclear cells transplantation in patients with ST-segment elevation myocardial infarction:4years follow-up. European Heart Journal . 2009
  • 5Armesilla DA,Elvira G,Silva A.p53regulates the proliferation,differentiation and spontaneous transformation of mesenchymal stem cells. Experimental Cell Research . 2009
  • 6Pulukuri SM,Rao JS.Activation of p53/p21Waf1/Cip1pathway by5-aza-2’’-deoxycytidine inhibits cell proliferation,induces pro-apoptotic genes and mitogen-activated protein kinases in human prostate cancer cells. International Journal of Oncology . 2005
  • 7Schuler M,Green DR.Transcription,apoptosis and P53:catch-22. Trends in Genetics . 2005
  • 8Deng W,Obrocka M,Fischer I,et al.In vitro differentiation of human marrow stromal cells into early progenitors of neural cells by conditions that increase intracellular cyclic AMP. Biochemical and Biophysical Research Communications . 2001
  • 9Wakitani S,Saito T,Caplan AI.Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle and Nerve . 1995
  • 10Makino S,Fukuda K,Miyoshi S,et al.Cardiomyocytes can be generated from marrow stromal cells in vitro. Journal of Clinical Investigation, The . 1999

二级参考文献12

  • 1李国草,李庚山,张静,李文强,周青.兔骨髓间充质干细胞自体移植治疗扩张型心肌病的实验研究[J].中华心血管病杂志,2004,32(12):1095-1098. 被引量:8
  • 2李文强,李艳,周永明,张静,李庚山.自体骨髓基质干细胞移植对扩张型心肌病家兔心功能的影响(英文)[J].中国现代医学杂志,2005,15(9):1293-1296. 被引量:4
  • 3Pittenger MF,Mackay AM,Beck SC,et al.Multilineage potential of adult human mesenchymal stem cells[].Science.1999
  • 4Deans R J,Moseley A B.Mesenchymal stem cells: biology and potential clinical uses[].Experimental Hematology.2000
  • 5Janssens S,Dubois C,Bogaert J,et al.Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial[].The Lancet.2006
  • 6Stamm C,Westphal B,Kleine HD,et al.Autologous bone-marrow stem-cell transplantation for myocardial regeneration[].The Lancet.2003
  • 7Horwitz EM,Prockop DJ,Fitzpatrick LA,et al.Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta[].Nature Medicine.1999
  • 8Quarto R,Mastrogiacomo M,Cancedda R,et al.Repair of large bone defects with the use of autologous bone marrow stromal cells[].New England Journal of Medicine The.2001
  • 9Wakitani S,Imoto K,Yamamoto T,et al.Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees[].Osteoarthritis and Cartilage.2002
  • 10Badiavas EV,Falanga V.Treatment of chronic wounds with bone marrow-derived cells[].Archives of Dermatology.2003

共引文献48

同被引文献45

  • 1关春艳,高航.骨髓基质干细胞向心肌细胞分化的研究进展[J].心血管病学进展,2009,30(6):1050-1053. 被引量:6
  • 2Cao H. Characterization of immortalized mesenehymal stem cells de- rived from foetal porcine pancreas. Cell Prolif,2011,44 : 19-32.
  • 3Bodnar AG, Ouellette M, Frolkis M, et al. Extension of life-span by in- troduction of telomerase into normal human cells. Science, 1998,279: 349-352.
  • 4Tsai CC, Chen CL, Liu HC, et al. Overexpression of hTERT increases stem-like properties and decreases spontaneous differentiation in hu- man mesenchymal stem cell lines. J Biomed Sci ,2010,17:64.
  • 5Asari T, Furukawa K, Tanaka S, et al. Mesenchymal stem cell isolation and characterization from human spinal ligaments. Biochem Biophys Raa Cammun _ 2012 _417.1193-1199.
  • 6Vemnesi F, Torricelli P, Borsari V, et al. Mesenehymal stem cells in the aging and osteopomtic population. Crit Rev Eukaryot C, ene Expr, 2011,21:363-377.
  • 7Jiang XR, Jimenez G, Chang E, et al. Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype. Nat Genet,1999 ,21:111-114.
  • 8Kang TJ, Yeom JE, Lee HJ, et al. Growth kinetics of human mesenchy- real stem ceils from bone marrow and umbilical cord blood. Acta Haemato1.2004 .112 :230-233.
  • 9Wexler SA, Donaldson C, Denning-Kendall P, et al. Adult bone mar- row is arichsource of human mezenchymal stem cells but umbilical cord and mobilized adult blood are not. Br J Haematol,2003,121: 368-374.
  • 10Williams AR. Mesenchymal stem cells : biology, pathophysiology, trans- lational findings, and therapeutic implications for cardiac disease. Circ Res ,2011,109:923-940.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部